Eosinophilic cystitis is a rare inflammatory disease of the bladder characterized by an increase in eosinophils in the wall of the organ. This condition is sometimes associated with allergic reactions and can manifest itself both as an independent pathology and in the context of other diseases. Eosinophilic cystitis is more often observed in women, although it can also occur in men and children. Symptoms include frequent urge to urinate, pain in the lower abdomen, discomfort and, in some cases, hematuria. The pathogenesis of the disease is not fully understood, but it is assumed that it is associated with immune-mediated mechanisms and possible allergic reactions.
History of the disease and interesting historical facts
Eosinophilic cystitis was first described in medical literature in the mid-20th century. However, its widespread recognition occurred only in the 1980s, when researchers began to study in detail its various manifestations and treatment methods. One of the first clinical cases was recorded in 1976, when a patient suffering from typical symptoms of bladder inflammation was found to have a high degree of eosinophilia in his body. Interesting fact: unlike other inflammatory diseases of the urinary tract, eosinophilic cystitis has a more pronounced connection with allergic factors, which attracted the attention of specialists in the field of allergology and immunology.
Epidemiology
Eosinophilic cystitis is a rare disease. According to various studies, its prevalence is approximately 0.5-1% of the total number of bladder diseases. Such data indicate that the disease is more common in women, with a clear predominance of cases in the 20-50 age group. In some populations, isolated cases are noted among children and adolescents. At the same time, no clear dependence of the incidence on race or ethnicity has been described, but it has been noted that people with an allergic history are more likely to develop the disease.
Genetic predisposition to this disease
Genetic research into eosinophilic cystitis is currently in its early stages. Some studies have suggested a potential link between genes involved in the immune response and the development of the disease. In particular, changes have been found in species-specific genes associated with eosinophilic activity, such as IL-5, which is responsible for stimulating the production of eosinophils in the bone marrow. These molecules are important in the pathogenesis of the disease, although the mechanisms by which they act require further study. There may also be an increased predisposition among patients with other allergic diseases, including asthma and allergic rhinitis, in their families.
Risk factors for the development of this disease
Risk factors that contribute to the development of eosinophilic cystitis include both physical and chemical agents. These include:
- Allergens: plant pollen, fungal spores, animal hair and food products.
- Chemicals: Medicines such as nonsteroidal anti-inflammatory drugs and antibiotics.
- Immune system problems: previous history of diseases such as allergic rhinitis, asthma and eczema.
- Infections: Certain types of urinary tract infections can make the condition worse.
Research shows that exposure to exogenous and endogenous factors can initiate the development of the disease, but this does not always precede its manifestation.
Diagnosis of this disease
Diagnosis of eosinophilic cystitis requires a comprehensive approach that takes into account clinical symptoms and the results of additional studies. The main symptoms include:
- Frequent urge to urinate.
- Pain in the lower abdomen.
- Discomfort when urinating.
- Hematuria.
Laboratory tests may include a urinalysis, which often shows eosinophils and other inflammatory changes. Radiological tests, such as ultrasound or MRI, may help rule out other conditions. Other diagnostics may include cystoscopy with a biopsy of the bladder wall to obtain morphological material. Differential diagnosis is important to rule out infections as well as more common forms of cystitis.
Treatment
Treatment for eosinophilic cystitis varies depending on the severity of the disease and the presence of associated manifestations. General treatment may include lifestyle changes and the elimination of possible allergens. Pharmacological treatment most often includes the administration of corticosteroids, antihistamines, and bronchodilators. Surgical treatment is indicated in rare cases and may include resection of the inflamed portion of the bladder. Other treatments, such as physical therapy, may be used to reduce symptoms.
List of medications used to treat this disease
- Prednisolone is a corticosteroid used to reduce inflammation.
- Loratadine is an antihistamine.
- Cetirizine is an antiallergic drug.
- Diclofenac is a non-steroidal anti-inflammatory drug.
- Topical corticosteroids - for local use in localized forms.
Each drug must be prescribed by a doctor, taking into account the individual characteristics of the patient.
Disease monitoring
Monitoring of eosinophilic cystitis includes regular control examinations to assess the dynamics of the disease. The prognosis with timely and adequate therapy is usually favorable, but relapses may occur. Complications may include chronic inflammation in the bladder, which must be taken into account when planning further patient management.
Age-related features of the disease
Eosinophilic cystitis has different manifestations depending on the patient's age. In children, the disease manifests itself without allergic diseases, unlike women of reproductive age, who have a complex relationship with allergic reactions. In older people, the disease may have a more severe course with a tendency to relapse, which requires an aggressive approach to treatment.
Questions and Answers
- What are the main symptoms of eosinophilic cystitis? The main symptoms include frequent urination, lower abdominal pain, and hematuria.
- What is the treatment for this disease? Treatment includes the use of corticosteroids, antihistamines, and topical therapies depending on the severity of the disease.
- What is the likelihood of relapse? The likelihood of relapse is high, especially in the absence of adequate treatment and taking into account the individual characteristics of the body.
- How is eosinophilic cystitis diagnosed? Diagnosis is based on clinical examination, laboratory and radiological studies, and cystoscopy.
- What is the relationship between the disease and allergies? Eosinophilic cystitis is often associated with allergic conditions, increasing the risk of its occurrence in patients with a history of allergies.
Advice from Dr. Oleg Korzhikov
It is important to remember that eosinophilic cystitis is a serious condition that requires careful monitoring. Be sure to monitor your symptoms and consult your doctor regularly. Try to avoid known allergens and maintain a healthy lifestyle. Proper nutrition and exercise can have a positive effect on the course of the disease. If you have questions about possible connections with other diseases, do not hesitate to seek advice from specialists.
